Share:

Research Awards Announced for ACOG 2018 Annual Meeting

April 26, 2018

Austin, Texas – The American College of Obstetricians and Gynecologists (ACOG) is pleased to announce the ACOG Annual Meeting research award winners, who were selected from among authors of more than 700 outstanding original research papers and posters to be presented at this year’s event.

“Challenges to medicine and science have never been more prevalent than they are today,” said J. Kell Williams, M.D., chair of ACOG’s Committee on Scientific Program. “Ob-gyns are on the forefront when it comes to navigating the ranging attitudes and misconceptions on best practices for women’s health. That is why it is more critical than ever that, through research, we continue to bring to the forefront the best scientific evidence and discovery.  It is my honor to announce the award-winning selections that represent the very best investigation into obstetric and gynecologic care.”

“The theme of this year’s annual meeting, ‘Medical and Surgical Innovations in Health Care,’ aims to help women’s health care providers stay abreast of the latest medical and technological advances to improve ob-gyn practice,” said ACOG President Haywood Brown, M.D. “ACOG fellows deserve to be recognized for the exemplary research they conduct in the effort to expand our understanding and knowledge of the science and medicine surrounding women’s health.”

Abstracts will be published in a special May 2018 supplement to Obstetrics & Gynecology (the Green Journal), and will be publicly available for six months. The prizes, titles, abstract numbers, first authors, and a brief overview are listed below. Learn more about the annual meeting and email communications@acog.org for embargoed copies of the abstracts.

 

First Prize
Effect of First Trimester Bleeding on Retained Placenta Requiring Dilatation and Curettage [20OP]
Marissa Le Gallee, BSc
Jewish General Hospital, Montreal, Canada
Evaluates the effect of a first trimester bleed on the need for a post-vaginal delivery D&C for removal of retained placenta.

Second Prize
HIV Vertical Transmission Does Not Differ When Using Protein Inhibitor or Integrase Inhibitor Antiretrovirals [17OP]
Luis M. Gomez, MD, MScE
Perinatal Associates of Northern Virginia—INOVA Health System, Fairfax, VA
Compares the rate of HIV vertical transmission in women receiving a protease inhibitor to those receiving integrase strand transfer inhibitors -based, combined-antiretroviral therapy.

Third Prize
Assisted Reproductive Technology and Stillbirth Risk: Selected States, 2006–2011 [15OP]
Jeani Chang, MPH
Centers for Disease Control and Prevention, Atlanta, GA
Examines trends and characteristics of stillbirths among pregnancies (live births and stillbirths) following assisted reproductive technology (ART) and to evaluate the association between ART and risk of stillbirth using linked ART surveillance and vital records from Connecticut, Florida, Massachusetts, and Michigan.

Donald F. Richardson Prize Paper (Junior Fellow papers submitted by ACOG’s 12 Districts)
Effect of Removal of Pregnancy Category on Prescribing in Pregnancy: A Randomized [5OP]
Angela Robinson, MD
Greenwich Hospital Department of Obstetrics and Gynecology, Yale New Haven Health, Greenwich, CT
To assess the degree to which the removal of pregnancy drug categories (A, B, C, and D) from labeling information affects the likelihood that providers will prescribe medications.

Donald F. Richardson Prize Paper
FOXO3 Expression in the Human Ovary [6OP]
Helen Paige Swenson, MD
Department of Obstetrics and Gynecology, College of Medicine, University of Florida, Gainesville, FL
Evaluates in a temporal manner protein localization of FOXO3 in pre- and postmenopausal human ovaries by immunohistochemistry.

Blue Ribbon
First Trimester Fasting Plasma Glucose Screen in Advanced Maternal Age to Detect Pre-existing Glucose Intolerance [22O]
Bethany T. Waites, BA
Oregon Health and Science University, Portland, OR
Examines the cost-effectiveness of first trimester fasting plasma glucose (FPG) screening in advanced maternal age women.

Blue Ribbon
Risk Screening for Hereditary Cancer During Obstetrical Care: Barriers to Testing and Health Disparities [27M]
Lannah L. Lua, MD
University of Nevada School of Medicine, Department of Obstetrics and Gynecology, Las Vegas, NV
Quantify the acceptance and efficacy of a focused hereditary cancer screening program initiated during pregnancy intake and determine if at-risk patients who accept gene testing have barriers to obtaining mutation screening.

Blue Ribbon
Prevalence of Abnormal Cervical And Vaginal Cytology In HIV-Infected Women Over The Age Of 65 [5N]
Kelsey Stewart
Baylor College of Medicine, Houston, TX
Evaluates the prevalence of abnormal cervical cytology/CIN and invasive neoplasia in HIV-infected women over the age of 65 with no history of abnormal Paps to aid in the creation of screening recommendations for this demographic.

To attend presentations of these and other posters representing the full range of research in women’s health, attend ACOG’s 2018 annual meeting in Austin, Texas, April 27–30, 2018. To register, email communications@acog.org.

 

###

The American College of Obstetricians and Gynecologists (ACOG) is the nation’s leading group of physicians providing health care for women. As a private, voluntary, nonprofit membership organization of more than 58,000 members, ACOG strongly advocates for quality health care for women, maintains the highest standards of clinical practice and continuing education of its members, promotes patient education, and increases awareness among its members and the public of the changing issues facing women’s health care. www.acog.org

American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188